Universal Health International Group Holding Ltd. released its earnings results on Feb 25, 2025. The company reported -HK$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.011.

Is Universal Health International Group Holding Ltd. overvalued?

According to Wall Street analysts Universal Health International Group Holding Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Universal Health International Group Holding Ltd. pay dividends?

Universal Health International Group Holding Ltd. pays a Notavailable dividend of HK$0.14 which represents an annual dividend yield of N/A. See more information on Universal Health International Group Holding Ltd. dividends here

What is Universal Health International Group Holding Ltd.’s EPS estimate?

Universal Health International Group Holding Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Universal Health International Group Holding Ltd. have?

Universal Health International Group Holding Ltd. has 801,059,600 shares outstanding.

What happened to Universal Health International Group Holding Ltd.’s price movement after its last earnings report?

Universal Health International Group Holding Ltd. reported an EPS of -HK$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Universal Health International Group Holding Ltd.?

Currently, no hedge funds are holding shares in HK:2211

---

Universal Health International Group Holding Ltd. Stock Smart Score

Outperform

Technicals

Fundamentals

Return on Equity

4.03%

Trailing 12-Months

Asset Growth

-22.11%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Universal Health International Group Holding Ltd.

Universal Health International Group Holding Limited, an investment holding company, engages in the distribution, wholesale, and retail of drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People's Republic of China. Its product categories include Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs, traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, prepackaged foods, nutritional foods, health care products, stereotyped packaging cosmetics, and daily necessities, as well as family planning supplies, such as contraceptives and utensils; dairy products comprise infant formula milk powder; etc. The company also provides storage services. It serves pharmaceutical retailers, hospitals, clinics, and distributors. The company was formerly known as Jintian Pharmaceutical Group Limited and changed its name to Universal Health International Group Holding Limited in July 2015. Universal Health International Group Holding Limited was founded in 1998 and is headquartered in Shenyang, the People's Republic of China.

---